SCHEDULES

SCHEDULE 4Integrated care system: minor and consequential amendments

National Health Service Act 2006

138

In Schedule 12A (pharmaceutical remuneration), in paragraph 2—

(a)

in the heading for “clinical commissioning groups” substitute “integrated care boards”;

(b)

in sub-paragraph (3), for “clinical commissioning group” substitute “integrated care board”;

(c)

in sub-paragraph (4), for “clinical commissioning groups” substitute “integrated care boards”;

(d)

in sub-paragraph (5), for “clinical commissioning group” substitute “integrated care board”;

(e)

in sub-paragraph (6)—

(i)

for “a clinical commissioning group” substitute “an integrated care board”;

(ii)

in paragraphs (a) and (b), for “the group”, in both places it occurs, substitute “the board”;

(f)

in sub-paragraph (8), for “a clinical commissioning group” substitute “an integrated care board”;

(g)

for sub-paragraph (9) substitute—

“(9)

For the purposes of sections 223GC and 223M(1)(b) and paragraph 22 of Schedule 1B, any amount of which an integrated care board is notified under sub-paragraph (6) is to be treated as expenditure of the group which is attributable to the performance by it of its functions in the year in question.”